191 related articles for article (PubMed ID: 287029)
1. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
Fibach E; Gambari R; Shaw PA; Maniatis G; Reuben RC; Sassa S; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
[TBL] [Abstract][Full Text] [Related]
2. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
Yamasaki H; Fibach E; Nudel U; Weinstein IB; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3451-5. PubMed ID: 269404
[TBL] [Abstract][Full Text] [Related]
3. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
[TBL] [Abstract][Full Text] [Related]
4. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
Chen Z; Banks J; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
Mager D; Bernstein A
J Cell Physiol; 1980 Dec; 105(3):519-26. PubMed ID: 6936401
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.
Yamasaki H; Drevon C; Martel N
Carcinog Compr Surv; 1982; 7():359-77. PubMed ID: 7039831
[No Abstract] [Full Text] [Related]
7. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.
Rovera G; O'Brien TG; Diamond L
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2894-8. PubMed ID: 268640
[TBL] [Abstract][Full Text] [Related]
8. Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.
Yamasaki H; Martel N; Fusco A; Ostertag W
Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2075-9. PubMed ID: 6326103
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.
Fibach E; Yamasaki H; Weinstein IB; Marks PA; Rifkind RA
Cancer Res; 1978 Nov; 38(11 Pt 1):3685-8. PubMed ID: 279396
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of induced murine erythroleukemia cell differentiation by tumor promoters: relation to the cell cycle.
Gambari R; Fibach E; Rifkind RA; Marks PA
Biochem Biophys Res Commun; 1980 Jun; 94(3):867-74. PubMed ID: 7396937
[No Abstract] [Full Text] [Related]
11. Induction of a novel nuclear protein (p54) by phorbol esters in mouse erythroleukemia (Friend) cells.
Mitsuse S; Oishi M
Cancer Res; 1985 Aug; 45(8):3836-42. PubMed ID: 3860288
[TBL] [Abstract][Full Text] [Related]
12. Desferrioxamine-mediated inhibition of heme and hemoglobin synthesis in murine erythroleukemia cells: expression of globin genes and commitment to erythroid differentiation.
Gambari R
Cell Biol Int Rep; 1983 Oct; 7(10):785-95. PubMed ID: 6580089
[TBL] [Abstract][Full Text] [Related]
13. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
Pilz RB
J Biol Chem; 1993 Sep; 268(27):20252-8. PubMed ID: 8376386
[TBL] [Abstract][Full Text] [Related]
14. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects.
Giroldi L; Hollstein M; Yamasaki H
Carcinogenesis; 1988 May; 9(5):817-21. PubMed ID: 3163274
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells.
Mallia CM; Aguirre V; McGary E; Tang Y; Scandurro AB; Liu C; Noguchi CT; Beckman BS
Exp Cell Res; 1999 Feb; 246(2):348-54. PubMed ID: 9925750
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoter-mediated effects on Friend leukemia cells induced by actinomycin D: flow microfluorometry analysis and erythroid differentiation.
Gambari R
Basic Appl Histochem; 1982; 26(3):163-72. PubMed ID: 7138458
[TBL] [Abstract][Full Text] [Related]
17. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
Watanabe T; Shafman T; Kufe DW
J Cell Physiol; 1985 Mar; 122(3):435-40. PubMed ID: 3918047
[TBL] [Abstract][Full Text] [Related]
18. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
Weich N; Marks PA; Rifkind RA
Blood; 1990 Jul; 76(2):302-6. PubMed ID: 2369636
[TBL] [Abstract][Full Text] [Related]
19. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by dexamethasone of commitment to erythroid differentiation in murine erythroleukemia cells.
Tsiftsoglou AS; Gusella JF; Volloch V; Housman DE
Cancer Res; 1979 Oct; 39(10):3849-55. PubMed ID: 289436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
